-
to scale and sustain the impact of the IBMC-i3S ERA Chair in Immunology. 3. Workplan: Immunomodulatory therapies for non-infectious diseases. T cells develop in the thymus and play a key role in the
-
immune cells. Significantly, the AHR can regulate melanogenesis and inflammation, has important roles in tumorigenesis (e.g. invasion, metastasis, cancer stem-cell development), and is implicated in drug
-
adequate inventory levels; Develop, update, and enforce Standard Operating Procedures (SOPs) and safety protocols; Ensure proper waste disposal and adherence to all relevant environmental, health, and safety
-
mice to develop the following tasks to: i) dissect the molecular pathways involved in alcohol-associated changes in glial cells and synapses; ii) identify molecular targets, relevant to the glia
-
Development Fund (FEDER) at IBMC, under the following conditions: 1. Scientific Area: Biology. 2. Project title: Beyond the ImmunoHUB: a complementary and multidisciplinary strategy to expand and sustain
-
November 11th to November 24th 2025. Applications must be submitted electronically at: https://dozer.i3s.up.pt/applicationmanagement/#/addapplications/8882ba2fa8fef3247e421c3161827795 The required documents
-
ANNOUNCEMENT OF A CALL FOR THE SELECTION OF A RESEARCH TECHNICIAN - Ref. IBMC_TI_ImmunoHUB_0511_2025
of presentation of applications: The competition is open from November 7th to November 20th 2025. Applications must be submitted electronically at: https://dozer.i3s.up.pt/applicationmanagement/#/addapplications